Eleva, Inc. – Trademark Portfolio

Entity Type: 03

Eleva, Inc. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. The owner is based in Salt Lake City, UT.

4505 South Wasatch Boulevard

Salt Lake City, UT 84124

18 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Eleva, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (12 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

14
Jewelry (2 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

39
Transportation & Storage (1 filing)

Transport; packaging and storage of goods; travel arrangement

Frequently Asked Questions

How many trademarks does Eleva, Inc. have?

Eleva, Inc. has 18 U.S. trademarks filed with the USPTO.

What trademark classes does Eleva, Inc. file in?

Eleva, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 14 (Jewelry), Class 9 (Computers & Electronics), Class 39 (Transportation & Storage). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Eleva, Inc.'s trademark registration success rate?

Eleva, Inc. has a 0% trademark registration rate, with 0 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.